INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Parikh Shamik J sold HUMA

Chief Medical Officer · Humacyte, Inc. · Common Stock

Side
SELL
Value
$41K
Shares
45.9K
Price
$0.9
Executed
May 18, 2026
Disclosed
May 20, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 18 executedMay 20, 2026 disclosed

HUMA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
14/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+5 / 25

    $41K reported value · 14.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HUMA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    KB
    Kuznik Paul BrianDirector
    HUMAHumacyte, Inc.
    Grant or award
    		A—
    125.0K sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    14
    SA
    Sander Dale A.CFO and Chief Corp. Dev. Off
    HUMAHumacyte, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$41K
    45.9K sh
    		May 18, 2026May 20, 2026
    traded May 18, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001916853-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 18, 2026
    Published
    May 20, 2026
    Ingested by INSIDER
    Nov 5, 03:57 UTC
    Last re-read
    Nov 5, 03:57 UTC

    Extracted facts

    Filer
    Parikh Shamik J
    Role
    Chief Medical Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Humacyte, Inc.
    Ticker
    HUMA
    Shares
    45.9K
    Price per share
    $0.9
    Value
    $41,147
    Execution date (reported)
    May 18, 2026
    Owned after transaction
    272.7K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 45.9K
    • Price: $0.8967

    = $41,147

    What this establishes

    Parikh Shamik J filed this Form 4 reporting a open-market sale of HUMA on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Parikh Shamik Jcik:0001916853
    Issuer
    Humacyte, Inc.cik:0001818382

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.